ArticlePharmaceuticals (Basel, Switzerland)2025

Efficacy of Tumor Necrosis Factor-α Inhibitor Adalimumab in Chronic Recurrent Vogt-Koyanagi-Harada Disease.

Junghoo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.